by Primary care physicians play a critical role in providing basic healthcare and preventing, managing, and treating chronic illnesses like diabetes, obesity, cardiovascular diseases and respiratory diseases. They help treat and care for patients with common acute and chronic illnesses, administer immunizations and conduct routine health screenings.
The global Primary Care Physicians Market is estimated to be valued at US$ 807.79 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The strong demand for managing the growing prevalence of chronic diseases across major countries has been a key growth driver for the primary care physicians market. Chronic diseases require prolonged treatment and management over a period of time. Primary care physicians act as the first point of contact for patients suffering from chronic conditions and can help prevent costly complications through regular screening, diagnostics and ongoing treatment. Their focus on preventive healthcare also helps reduce the burden of advanced stage chronic diseases on healthcare systems globally. The COVID-19 pandemic has further highlighted the need for strengthening primary healthcare systems, which is expected to boost investments and focus on this market space over the forecast period.
Segment Analysis
The global primary care physicians market is segmented by type into general practitioners, pediatricians, internal medicine physicians, and family medicine physicians. The family medicine physicians segment dominates the market owing to the increasing prevalence of chronic diseases which require continuous treatment and monitoring. Family physicians provide comprehensive and continuous medical care for both acute and chronic illnesses.
Key Takeaways
The Global Primary Care Physicians Market Demand is expected to witness high growth. The global Primary Care Physicians Market is estimated to be valued at US$ 807.79 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024-203.
North American region dominates the primary care physicians market currently due to the increasing geriatric population suffering from chronic diseases in countries like US.
Key players operating in the primary care physicians market are Roche, Johnson & Johnson, Novartis, and Amgen. Roche offers pharmaceuticals and diagnostics for various therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, etc.
Johnson & Johnson provides healthcare solutions through its pharmaceutical, medical device, and consumer packaged goods businesses. Novartis focuses on developing innovative medicines to address unmet medical needs through its Pharmaceuticals, Oncology, and Sandoz divisions. Amgen discovers, develops, manufactures, and delivers innovative human therapeutics for grievous illness.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.
